ACM Research (ACMR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Voting matters and shareholder proposals
Election of four directors: Haiping Dun, Tracy Liu, David H. Wang, and Charlie Pappis, all recommended for approval by the board.
Ratification of Ernst & Young Hua Ming LLP as independent auditor for 2025, recommended for approval.
Board of directors and corporate governance
Board recommends the election of all nominated directors for the upcoming term.
Audit committee and external auditor matters
Proposal to ratify Ernst & Young Hua Ming LLP as the independent auditor for the 2025 fiscal year.
Partial view of Summaries dataset, powered by Quartr API
Latest events from ACM Research
- 2025 revenue hit $901.3M, with 2026 guidance for 21–30% growth despite margin pressure.ACMR
Q4 202526 Feb 2026 - Q2 revenue up 40% to $202.5M, margins strong, 2024 guidance raised, new products launched.ACMR
Q2 20242 Feb 2026 - Q3 revenue up 21% to $204M, margins strong, 2024 outlook raised, global expansion ongoing.ACMR
Q3 202416 Jan 2026 - Supply chain localization and product innovation drive growth amid export controls and market shifts.ACMR
UBS Global Technology and AI Conference11 Jan 2026 - 2024 revenue rose 40% to $782.1M, with strong margins and a robust 2025 outlook.ACMR
Q4 202423 Dec 2025 - Shareholders will elect four directors and ratify the auditor at a virtual 2025 annual meeting.ACMR
Proxy Filing1 Dec 2025 - Q1 2025 revenue up 13.2% year-over-year, with net income and cash rising but margin lower.ACMR
Q1 202525 Nov 2025 - Q2 2025 revenue grew 6.4% to $215.4M, with margin gains and robust global expansion outlook.ACMR
Q2 202523 Nov 2025 - Q3 2025 revenue up 32% to $269.2M; margin pressure and trade risks remain.ACMR
Q3 202513 Nov 2025